Cardiovascular Disease, Arrhythmias
Conditions
Keywords
Parasympathetic activity, Exercise, Education, Arrhythmias, Defibrillators, Implantable
Brief summary
The current research study proposes to examine participants with implantable cardioverter defibrillators (ICD) who are randomly assigned to either an exercise training program intervention or a heart healthy education program intervention. We will look at changes in the functioning of the autonomic nervous system over time and between intervention groups. We are also going to be looking at changes in frequencies of the ICD participants' heart arrhythmias and ICD therapies (e.g., pacing, shock).; as well as, changes in exercise tolerance, psychological well-being, and quality of life.
Interventions
BEHAVIORALExercise
moderate-intensity, low-impact, supervised, aerobic exercise
BEHAVIORALHeart Healthy Education
Educational topics related to heart health (e.g., nutrition, smoking, sleep)
Sponsors
The Miriam Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* adult ICD patients (≥ 18 years of age) * received an ICD for secondary prevention, cardiac diagnosis of: ventricular fibrillation, OR ventricular tachycardia, OR cardiac arrest, OR syncope with ventricular tachycardia inducible by programmed stimulation (EPS), AND * either diagnosed coronary artery disease AND/OR prior myocardial infarction, or non-ischemic dilated cardiomyopathy * meet functional NYHA Class I or II heart failure or angina symptoms * ICD patients need to be sedentary, defined as not engaging in structured exercise more than once weekly, or an accumulation of less than 60 minutes of moderate intensity aerobic activity over the course of the week, for the past 3 months. * deemed medically stable by their cardiologist and have received approval by their cardiologist to engage in an exercise program * Stable (unchanged) cardiac and psychopharmacologic medications in the 3 months prior to study enrollment * Able to read and write English * able to commit to the 3-month exercise/heart healthy program attending 3 times per week (36 sessions) * able to commit to the 3 assessments (pre, post-treatment, 3-month follow-up; 6-month duration)
Exclusion criteria
* Patients who meet functional NYHA Class III or IV heart failure or angina symptoms * sinus node dysfunction that requires atrial pacing * atrial fibrillation * bi-ventricular ICD * are pacemaker-dependent * diagnosis of Brugada's Syndrome * diagnosis of arrhythmogenic right ventricular dysplasia * complex congenital heart disease * orthopedic restrictions, limitations, or disabilities that would jeopardize the patient's safety during exercise or form completing the treadmill stress test * Neurocognitive or cognitive impairments that will result in nonadherence (based on clinical evaluation) * Unstable angina * resting systolic blood pressure \>180mmHg or resting diastolic blood pressure \>110mm Hg will be evaluated on a case-by-case basis * orthostatic blood pressure drop of \>20mm Hg with symptoms * critical aortic stenosis (peak systolic pressure gradient \>50mm Hg with aortic valve orifice area \<0.75cm2 in average size adult) * acute systemic illness or fever * uncontrolled atrial or ventricular arrhythmias * uncontrolled sinus tachycardia (\>120 beats/min) * uncompensated CHF * 3rd degree AV block (without pacemaker) * active pericarditis or myocarditis * recent embolism; thrombophlebitis * resting ST segment displacement (\>2mm) * uncontrolled diabetes (resting blood glucose \>400mg/dl) * metabolic problems, such as acute, hypo or hyperkalemia, hypovolemia * recent strongly positive exercise test as achieved by: significant decrease in systolic blood pressure with increasing workload, OR early onset, horizontal or downsloping ST segment depression (4mm), OR prolonged electrocardiogram (ECG) changes during recovery * hypertrophic obstructive cardiomyopathy * severe pulmonary hypertension * patients who do not pass the exercise stress test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| parasympathetic activity and regulation | 3 months, 6 months |
Secondary
| Measure | Time frame |
|---|---|
| arrhythmia frequency | 3 months, 6 months |
| ICD therapy frequency | 3 months, 6 months |
| exercise tolerance | 3 months, 6 months |
| psychological well-being | 3 months, 6 months |
| quality of life | 3 months, 6 months |
Countries
United States
Outcome results
None listed